Tag: such-as-heart

(Reuters) – Portola Pharmaceuticals Inc said late-stage data showed its oral anticoagulant was not superior to an injectable standard therapy in preventing blood clots in acutely ill patients. There was no statistical difference in major bleeding between the patients who were treated with Portola’s drug, betrixaban, and those given the injectable, enoxaparin, in the study,…